Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study

By A. Menezes, R. Perez-Padilla, J. R. Jardim, Adriana Muiño, M. Lopez, G. Valdivia, Maria Ana MONTES DE OCA, C. Tálamo, P. Hallal, C. Victora. The Lancet, 2005

1,046 citations recorded by the source corpus.

Subfields: Emergency Medical Services, Health, Toxicology and Mutagenesis, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/2d9cbf513232c6de84000c9caf2cab5d6f653874

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Emergency Medical Services

1. P. Barnes
2. David M. Mannino

In Pulmonary and Respiratory Medicine

1. P. Barnes
2. David M. Mannino
3. A. Buist
4. R. Rodríguez-Roisín
5. C. Jenkins
6. Sonia Buist
7. Jan Zieliński
8. Yoshinosuke Fukuchi

Citations in the corpus

• Ageing and the epidemiology of multimorbidity (2014, neutral): “Data from [17, 18].”
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, background): “A prevalence study in Latin America (19), a systematic review and meta-analysis of studies performed in 28 countries between 1990 and 2004 (15), and an additional study from Japan (16) provide evidence that the prevalence of COPD (stage I, mild COPD and higher) is appreciably higher in smokers and e”
• Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. (2007, background): “The prevalence of COPD in China varied with geographic area, gender, and age, which is consistent with other studies (18, 24).”
• Global burden of COPD: systematic review and meta-analysis (2006, methodology): “Both the BOLD initiative and PLATINO have embraced systematic quality control criteria for spirometry as an essential component of their programmes [6, 85 ].”
• An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. (2010, methodology): “Further evidence of the role of other risk factors is the occurrence of COPD among neversmokers, with prevalence estimates ranging from approximately 3 to 15% in various populations using different methods (31, 36).”
• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, neutral): “В Латиноамериканском проекте по изуче нию обструктивной болезни легких (Latin American Project for the Investigation of Obstructive Lung Disease, PLATINO) [11] оценивали распространенность постброн ходилатационного ограничения скорости воздушного потока у лиц в возрасте старше 40 лет в пяти крупных ”